HOWL - Financial Reports List - Werewolf Therapeutics, Inc. - IntrinsicAlpha

Werewolf Therapeutics, Inc. HOWL

Healthcare - Biotechnology - NASDAQ - US

$ 1.08

-5.26 %

$ 48.5 M

Market Cap

-0.66

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	0.00%	-11.71%	100.00%
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-69.96%	-56.98%
Annual Report	FY	10-K	2024-12-31	-90.55%	-88.70%	-81.70%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-101.24%	-85.10%
Quarterly Report	Q2	8-K	2024-06-30	-85.86%	-238.35%	-212.51%
Quarterly Report	Q1	8-K	2024-03-31	-83.38%	-35.14%	-40.41%
Quarterly Report	Q4	8-K	2023-12-31	-79.39%	-12.38%	1.65%
Annual Report	FY	10-K	2023-12-31	21.60%	27.53%	27.75%
Quarterly Report	Q3	8-K	2023-09-30	18.65%	26.99%	26.22%
Quarterly Report	Q2	8-K	2023-06-30	94.82%	64.14%	59.48%

1